Thus, the vampire reference comes from PCT's effect on the skin when exposed to sunlight (photosensitivity). According to the Genetic and Rare Diseases Information Center (GARD), PCT is a ...

The patient was diagnosed with a rare and life-threatening condition that required him to undergo a two-hour surgery. Without ...

Butterfly disease is a collection of very rare genetic conditions that cause severe skin fragility. Even the slightest pressure or friction from clothing, touch, or minor injuries can cause the ...

That was a modest wager on a drug that stood a chance of becoming the first FDA-approved topical therapy for congenital ichthyosis, a collection of around 20 rare skin disorders that cause dry ...

This rare skin disorder causes flat brown spots ... Long-term exposure to ultraviolet rays without protection is to blame for many skin problems. Thickened, ulcerated spots called actinic ...

LIG4 syndrome is an exceptionally rare disorder caused by a genetic mutation that prevents the body from repairing damaged DNA.

New Delhi: Finally, there is some hope for patients suffering from rare and life-threatening skin disorders, as the existing national policy for rare diseases, which currently covers 63 conditions ...

A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology. Cutaneous T ...

Affecting both men and women, this rare but serious condition often goes undiagnosed due to a lack of awareness and its tendency to mimic other skin conditions. Dr Emily Alfonsi from Shade Skin ...

DEBRA Research and LEO Pharma enter strategic partnership to advance treatments for rare skin diseases: Munich, Germany Thursday, February 6, 2025, 10:00 Hrs [IST] DEBRA Research ...

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening ... treat other skin diseases, such as palmoplantar ...